Quetiapine 200 mg
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety, Contamination
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| All lots | A. Quetiapine 200 mg | - Recalling Firm
- Sanis Health Inc.
- 333 Champlain Street, Suite 102
- Dieppe
- E1A 1P2
- New Brunswick
- CANADA
- Marketing Authorization Holder
- Sanis Health Inc.
- 333 Champlain Street, Suite 102
- Dieppe
- E1A 1P2
- New Brunswick
- CANADA
| Tablet | DIN 02353199 | 200 mg |
Recalled Products
-
Quetiapine 200 mg
Potential cross-contamination of trace amounts of Clindamycin in Quetiapine Active Pharmaceutical Ingredient during the manufacturing process.
Distributed to wholesalers/pharmacies across Canada.